Basic Study
Copyright ©The Author(s) 2015.
World J Gastroenterol. May 28, 2015; 21(20): 6206-6214
Published online May 28, 2015. doi: 10.3748/wjg.v21.i20.6206
Table 1 Relationship between COX-2/HER-2 expression and clinicopathologic factors n (%)
VariablenCOX-2
HER-2
PositiveNegativeχ2P valuePositiveNegativeχ2P value
Sex2.3000.1292.7690.096
Male595454 (76.3)62 (20.0)288 (48.4)307 (51.6)
Female431346 (80.2)32 (15.1)186 (43.2)245 (56.8)
Age (yr)2.0110.1561.4960.221
< 60493375 (76.1)40 (16.3)218 (44.2)275 (55.8)
≥ 60533425 (79.7)54 (19.6)256 (48.0)277 (52.0)
Tumor site2.0070.1572.4990.114
Rectum542432 (79.7)45 (16.3)263 (48.5)279 (51.5)
Colon484368 (76.0)49 (19.9)211 (43.6)273 (56.4)
Tumor size4.9880.02633.1750.000
< 5 cm648489 (75.5)159 (24.5)255 (39.4)393 (60.6)
≥ 5 cm378308 (81.5)70 (18.5)219 (57.9)159 (42.1)
Serosal invasion11.1300.00110.6970.001
No266188 (70.7)78 (29.3)100 (37.6)166 (62.4)
Yes760612 (80.5)148 (19.5)374 (49.2)386 (50.8)
Differentiation6.5530.0386.9110.032
Well155114 (73.5)41 (26.5)67 (43.2)88 (56.8)
Moderate589476 (80.8)113 (19.2)258 (43.8)331 (56.2)
Poor282210 (74.5)72 (25.5)149 (52.8)133 (47.2)
Duke’s stage15.1910.00062.0450.000
A + B491357 (72.7)134 (27.3)164 (33.4)327 (66.6)
C + D535443 (82.8)92 (17.2)310 (57.9)225 (42.1)
Lymph node metastasis14.8650.00040.4300.000
Yes595506 (85.0)89 (15.0)325 (54.6)270 (45.4)
No431294 (68.2)137 (31.8)149 (34.6)282 (65.4)
Distal metastasis3.9280.0473.9010.048
Yes141119 (84.4)22 (15.6)76 (53.9)65 (46.1)
No885681 (76.9)204 (23.1)398 (45.0)487 (55.0)
Table 2 Relationship between COX-2 and HER-2 expression
COX-2 expressionHER-2 expression
Totalχ2P value
PositiveNegative
Positive3504508008.7620.003
Negative124102226
Total4745521026